AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Fulvestrant gives prolonged response in women with advanced breast cancer.(Brief Article)

Women's Health Weekly

| July 04, 2002 | COPYRIGHT 2002 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2002 JUL 4 - (NewsRx.com & NewsRx.net) -- Encouraging data presented at the American Society of Clinical Oncology (ASCO) have shown that Faslodex is at least as effective as Arimidex in the treatment of hormone receptor positive postmenopausal women with advanced breast cancer. It also provides a longer mean duration of response in this setting. This promising finding adds to a growing body of evidence to support Faslodex use in the advanced setting, suggesting it is a valuable additional endocrine treatment option for these patients.

Previous data analysis has already shown that the use of Faslodex following antiestrogen therapy for advanced disease does not compromise the potential for efficacy of subsequent endocrine agents, such as aromatase inhibitors or progestins. Faslodex may therefore play a crucial role in extending the overall therapeutic window of opportunity for the use of endocrine treatment modalities in advanced disease.

Faslodex has recently been approved by the U.S. Food and Drug Administration for the treatment of hormone receptor positive metastatic breast cancer in postmenopausal women with disease progression following ...

Related articles from newspapers, magazines, journals, and more
FASLODEX(R) (Fulvestrant) Added to Nationally Recognized Breast Cancer...
Press release article from: PR Newswire April 24, 2003 700+ words
...Guidelines in Oncology for Breast Cancer." FASLODEX is included in their...postmenopausal women with breast cancer, treatment with FASLODEX showed a decrease...estrogen receptors in breast cancer cells. FASLODEX is administered as...
New Breakthrough Treatment For Breast Cancer, Faslodex Launched In UK Today.
Press release article from: PR Newswire May 12, 2004 700+ words
...provides new choice for women with advanced breast cancer. A new breast cancer drug, Faslodex(TM) (fulvestrant), was launched today...quality of life for women with advanced breast cancer. Faslodex is a long-acting, once-monthly injection...
New Clinical Trial of FASLODEX(R) (Fulvestrant) Seeks to Identify Additional...
Press release article from: PR Newswire August 6, 2003 700+ words
...effectiveness of FASLODEX in patients with advanced breast cancer whose disease has...postmenopausal women with breast cancer, treatment with FASLODEX showed a decrease...estrogen receptors in breast cancer cells. FASLODEX is administered...
New Data Reported on FASLODEX(R) (Fulvestrant) Injection in Postmenopausal...
Press release article from: PR Newswire December 11, 2004 700+ words
...treatment with FASLODEX in 67 postmenopausal...women with advanced breast cancer who had previously...treatment with FASLODEX in 77 postmenopausal...women with advanced breast cancer, who had disease...as tamoxifen. FASLODEX is the only approved...therapy for advanced ...
Survival Analysis Supports Use of FASLODEX as an Effective Option for...
Press release article from: PR Newswire December 5, 2003 700+ words
...FDA) approved FASLODEX in 2002 for the...positive metastatic breast cancer in postmenopausal...as tamoxifen. FASLODEX is the only approved...therapy for advanced breast cancer administered as...positive metastatic breast cancer. The trial, called...Evaluation of ...
FASLODEX AS EFFECTIVE AS ARIMIDEX IN ADVANCED BREAST CANCER.
News wire article from: AsiaPulse News December 8, 2003 700+ words
...women with advanced breast cancer treated with the...receptor antagonist, 'Faslodex', have comparable...reminders of their breast cancer. The data confirm that 'Faslodex' is a valuable...positive metastatic breast cancer in post-menopausal...
Clinical potential of Faslodex established in Phase III data.(breast cancer)
Magazine article from: Women's Health Weekly October 31, 2002 700+ words
...resistant advanced breast cancer, confirming that Faslodex works in a...receptor, Faslodex targets and...receptors in breast cancer cells. In...Henderson, a noted breast cancer expert from...concludes that Faslodex is one of a...
Analysis shows Faslodex effective in treating metastatic breast cancer.
Newspaper article from: Pharma Business Week December 29, 2003 700+ words
...FDA) approved Faslodex in 2002 for the...positive metastatic breast cancer in postmenopausal...as tamoxifen. Faslodex is the only approved...therapy for advanced breast cancer administered as...positive metastatic breast cancer. The trial, called...Evaluation of ...
For more facts and information, see all results
©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA